Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Abstract:

PURPOSE:To provide an overview of fundamental concepts in machine learning (ML), review the literature on ML applications in imaging analysis of pituitary tumors for the last 10 years, and highlight the future directions on potential applications of ML for pituitary tumor patients. METHOD:We presented an overview of the fundamental concepts in ML, its various stages used in healthcare, and highlighted the key components typically present in an imaging-based tumor analysis pipeline. A search was conducted across four databases (PubMed, Ovid, Embase, and Google Scholar) to gather research articles from the past 10 years (2009-2019) involving imaging related to pituitary tumor and ML. We grouped the studies by imaging modalities and analyzed the ML tasks in terms of the data inputs, reference standards, methodologies, and limitations. RESULTS:Of the 16 studies included in our analysis, 10 appeared in 2018-2019. Most of the studies utilized retrospective data and followed a semi-automatic ML pipeline. The studies included use of magnetic resonance imaging (MRI), facial photographs, surgical microscopic video, spectrometry, and spectroscopy imaging. The objectives of the studies covered 14 distinct applications and majority of the studies addressed a binary classification problem. Only five of the 11 MRI-based studies had an external validation or a holdout set to test the performance of a final trained model. CONCLUSION:Through our concise evaluation and comparison of the studies using the concepts presented, we highlight future directions so that potential ML applications using different imaging modalities can be developed to benefit the clinical care of pituitary tumor patients.

journal_name

Pituitary

journal_title

Pituitary

authors

Saha A,Tso S,Rabski J,Sadeghian A,Cusimano MD

doi

10.1007/s11102-019-01026-x

subject

Has Abstract

pub_date

2020-06-01 00:00:00

pages

273-293

issue

3

eissn

1386-341X

issn

1573-7403

pii

10.1007/s11102-019-01026-x

journal_volume

23

pub_type

杂志文章,评审
  • Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas.

    abstract::In order to explore the presence of, and the potential role of, secretagogin in human pituitary adenomas, an analytical strategy that integrated comparative proteomics and comparative transcriptomics was used to detect the protein and the mRNA expression, respectively, of secretagogin in human non-functional pituitary...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/b:pitu.0000023426.99808.40

    authors: Zhan X,Evans CO,Oyesiku NM,Desiderio DM

    更新日期:2003-01-01 00:00:00

  • Ancient views on the hypothalamic-pituitary-thyroid axis: an historical and epistemological perspective.

    abstract::The modern views on the anatomical and physiological interactions between the hypothalamus, pituitary and thyroid gland have emerged only in the last fifty years, although their historical roots may be found in a number of ancient and still not widely known ideas and observations. The regulation of energy body stores ...

    journal_title:Pituitary

    pub_type: 历史文章,杂志文章

    doi:10.1023/a:1009953723963

    authors: Toni R

    更新日期:2000-10-01 00:00:00

  • Clinical characteristics of acromegalic patients with empty sella and their outcomes following transsphenoidal surgery.

    abstract:PURPOSE:To analyze the clinical characteristics of acromegalic patients with empty sella (ES, herniation of the subarachnoid space within the sella turcica) and the impact of ES on transsphenoidal surgery in such patients. METHODS:Seventy-eight patients, newly diagnosed with acromegaly who underwent transsphenoidal su...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-017-0798-6

    authors: Sasagawa Y,Hayashi Y,Tachibana O,Oishi M,Fukui I,Iizuka H,Nakada M

    更新日期:2017-08-01 00:00:00

  • Hypopituitarism in five PROP1 mutation siblings: long-lasting natural course and the effects of growth hormone replacement introduction in middle adulthood.

    abstract::Twenty years after the first description of combined hypopituitarism (CPHD) caused by PROP1 mutations, the phenotype of affected subjects is still challenging for clinicians. These patients suffer from pituitary hormone deficits ranging from IGHD to panhypopituitarism. ACTH deficiency usually develops later in life. P...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-020-01049-9

    authors: Doknic M,Gasic V,Stojanovic M,Pavlovic S,Marinkovic S,Miljic D,Pekic S,Manojlovic-Gacic E,Damjanovic D,Soldatovic I,Petakov M

    更新日期:2020-08-01 00:00:00

  • Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

    abstract:PURPOSE:Patients treated for pituitary adenomas generally report a reduced quality of life (QoL). At present, the patient's perspective of QoL has not been fully addressed and this, and further insight in potential determinants of QoL in pituitary diseases is required to design strategies to improve QoL. We aimed to de...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-014-0561-1

    authors: Andela CD,Niemeijer ND,Scharloo M,Tiemensma J,Kanagasabapathy S,Pereira AM,Kamminga NG,Kaptein AA,Biermasz NR

    更新日期:2015-02-01 00:00:00

  • Cushing's disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review.

    abstract::The dexamethasone (DXM) test has been widely used for diagnosing Cushing's disease (CD). The purpose of this paper is to review its diagnostic merit based on calculation of data extracted from earlier publications. Studies presenting individual values for patients with CD and normal subjects were identified through Pu...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-013-0509-x

    authors: Lindholm J

    更新日期:2014-08-01 00:00:00

  • Aerosolisation in endonasal endoscopic pituitary surgery.

    abstract:PURPOSE:To determine the particle size, concentration, airborne duration and spread during endoscopic endonasal pituitary surgery in actual patients in a theatre setting. METHODS:This observational study recruited a convenience sample of three patients. Procedures were performed in a positive pressure operating room. ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-021-01125-8

    authors: Dhillon RS,Nguyen LV,Rowin WA,Humphries RS,Kevin K,Ward JD,Yule A,Phan TD,Zhao YC,Wynne D,McNeill PM,Hutchins N,Scott DA

    更新日期:2021-01-19 00:00:00

  • Medical combination therapies in Cushing's disease.

    abstract:INTRODUCTION:There has been growing interest on medical therapy for the management of Cushing's disease (CD), particularly in cases of persistent or recurrent hypercortisolism. Ketoconazole, an inhibitor of adrenal steroidogenesis, is the most widely used drug, whereas cabergoline and pasireotide are the most promising...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-015-0641-x

    authors: Vilar L,Naves LA,Machado MC,Bronstein MD

    更新日期:2015-04-01 00:00:00

  • Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging.

    abstract::The availability of various first-line treatment modalities for acromegaly and evolving surgical techniques emphasize the need for accurately defined predictors of surgical outcome. We retrospectively analysed the outcome of 30 patients with acromegaly after initial endoscopic transsphenoidal surgery in two university...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0395-7

    authors: van Bunderen CC,van Varsseveld NC,Baayen JC,van Furth WR,Aliaga ES,Hazewinkel MJ,Majoie CB,Freling NJ,Lips P,Fliers E,Bisschop PH,Drent ML

    更新日期:2013-06-01 00:00:00

  • Diabetes insipidus, secondary hypoadrenalism and hypothyroidism after traumatic brain injury: clinical implications.

    abstract::Adequate ADH secretion, adrenal and thyroid functions are vital during the acute and post-acute phases of TBI. Deficiencies of these functions as a result of TBI are increasingly recognized. During the acute phase of TBI the incidence of severe DI is 2.9%; the incidence of less severe forms of DI is 21.6-26%. The deve...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-006-6049-x

    authors: Tsagarakis S,Tzanela M,Dimopoulou I

    更新日期:2005-01-01 00:00:00

  • Apoplexy in non functioning pituitary adenoma after one dose of leuprolide as treatment for prostate cancer.

    abstract::We report the case of a 60 year old male who complained of headache and blurry vision--that progressed to left ophthalmoplegia and ptosis--after receiving a dose of leuprolide for Prostate cancer therapy. Imaging showed a hemorrhagic sellar mass. The patient underwent transsphenoidal debulking, and the tissue obtained...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-009-0202-2

    authors: Guerra Y,Lacuesta E,Marquez F,Raksin PB,Utset M,Fogelfeld L

    更新日期:2010-01-01 00:00:00

  • Medical management of pituitary adenomas: structural and ultrastructural changes.

    abstract::The morphology of the various pituitary cell types is highly dynamic and allows recognition of many cellular functions. Most pituitary cells show morphologic changes that reflect stimulation or inhibition by hormones. Drugs have also been shown to alter the morphology of several pituitary tumor types, allowing a measu...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1022320732718

    authors: Asa SL,Ezzat S

    更新日期:2002-01-01 00:00:00

  • Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials.

    abstract:PURPOSE:Doses of growth hormone in adults with growth hormone deficiency are now lower than previously. However, it is not clear they are as effective as higher doses. The objective of this meta-analysis was to assess efficacy of low to moderate dose (LD) GH replacement on standard endpoints of GH compared to higher do...

    journal_title:Pituitary

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s11102-014-0571-z

    authors: Newman CB,Carmichael JD,Kleinberg DL

    更新日期:2015-06-01 00:00:00

  • Management of aggressive pituitary adenomas: current treatment strategies.

    abstract::Aggressive pituitary adenomas are notoriously difficult to manage due to their size, invasiveness, speed of growth and high frequency of recurrence. Except for prolactinomas, surgery (usually transsphenoidal but sometimes transcranial) is the first-line option, but re-growth of aggressive tumors is almost inevitable a...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-008-0153-z

    authors: Buchfelder M

    更新日期:2009-01-01 00:00:00

  • Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis.

    abstract:PURPOSE:Hypophysitis develops in up to 19% of melanoma patients treated with ipilimumab, a cytotoxic T-lymphocyte antigen-4 antibody. Early detection may avert life-threatening hypopituitarism. We aimed to assess the incidence of ipilimumab-induced hypophysitis (IH) at a quaternary melanoma referral centre, and to dete...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-018-0866-6

    authors: De Sousa SMC,Sheriff N,Tran CH,Menzies AM,Tsang VHM,Long GV,Tonks KTT

    更新日期:2018-06-01 00:00:00

  • Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment.

    abstract::We report the results of long-term (6-year) treatment of Nelson's syndrome with the long-acting dopamine agonist, cabergoline, in a 55-year-old woman. The disease presented 26 years after bilateral adrenalectomy and radiation treatment for Cushing's disease, followed by glucocorticoid and mineralocorticoid replacement...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-006-9290-4

    authors: Shraga-Slutzky I,Shimon I,Weinshtein R

    更新日期:2006-01-01 00:00:00

  • Dopamine resistance of prolactinomas.

    abstract::Resistance to dopamine agonists can be defined with respect to failure to normalize PRL levels and failure to decrease tumor size by > or = 50%. Using these definitions, failure to normalize PRL levels is seen in 24% of those treated with bromocriptine, 13% of those treated with pergolide and 11% of those treated with...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1026225625897

    authors: Molitch ME

    更新日期:2003-01-01 00:00:00

  • Cabergoline decreases somatotroph adenoma size: a case report.

    abstract::Dopamine agonists have been shown to reduce growth hormone secretion in some patients with acromegaly, but their effect on adenoma size has not been well appreciated. We describe a 69 year-old woman with acromegaly caused by a somatotroph macroadenoma who received primary treatment with the dopamine agonist cabergolin...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-005-5353-1

    authors: Rickels MR,Snyder PJ

    更新日期:2004-01-01 00:00:00

  • Sella turcica: an anatomical, endocrinological, and historical perspective.

    abstract:INTRODUCTION:The sphenoid bone has a superior depression called the sella turcica, Latin for "Turkish saddle," where the pituitary gland is found. The availability of modern radiological imaging techniques has replaced plain radiography of the sella turcica in the investigation of hypothalamo-pituitary abnormalities. H...

    journal_title:Pituitary

    pub_type: 历史文章,杂志文章,评审

    doi:10.1007/s11102-014-0609-2

    authors: Tekiner H,Acer N,Kelestimur F

    更新日期:2015-08-01 00:00:00

  • IGF-I assays: current assay methodologies and their limitations.

    abstract::The diagnosis of disorders of growth hormone (GH) is dependent upon accurate measurement of insulin-like growth factor-I (IGF-I) concentrations since serum IGF-I assays have been found to be useful as a screening tests for the presence of growth hormone deficiency (GHD) in children and in both children and adults they...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-007-0032-z

    authors: Clemmons DR

    更新日期:2007-01-01 00:00:00

  • Phospho-histone H3 (pHH3) immuno-reactivity as a prognostic marker in non-functioning pituitary adenomas.

    abstract::Nonfunctioning pituitary adenomas (NFPA) are typically benign neoplasms that can cause significant morbidity through local mass effects. MIB-1/Ki-67 and p53 immuno-reactivity are used to predict aggressive behavior but have known limitations. No marker to date is widely used to reliably predict tumor progression. Phos...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-011-0367-3

    authors: Hightower E,Cabanillas ME,Fuller GN,McCutcheon IE,Hess KR,Shah K,Waguespack SG,Corley LJ,Devin JK

    更新日期:2012-12-01 00:00:00

  • Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy.

    abstract::Hyperprolactinemia has been associated with impaired metabolism, including insulin resistance. However, the metabolic effects of elevated prolactin (PRL) levels are not completely clarified. The aim of this study was to obtain more insights of metabolic consequences in hyperprolactinemia patients. Fourteen consecutive...

    journal_title:Pituitary

    pub_type: 临床试验,杂志文章

    doi:10.1007/s11102-010-0277-9

    authors: Berinder K,Nyström T,Höybye C,Hall K,Hulting AL

    更新日期:2011-09-01 00:00:00

  • Adamantinomatous craniopharyngiomas express tumor stem cell markers in cells with activated Wnt signaling: further evidence for the existence of a tumor stem cell niche?

    abstract:INTRODUCTION:Early disease onset, clinical manifestation, histomorphology, and increased tendency to relapse distinguish the adamantinomatous craniopharyngioma (adaCP) from the more favorable papillary variant (papCP). A molecular hallmark of adaCP is the activated Wnt signaling pathway indicated by nuclear β-catenin a...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-013-0543-8

    authors: Hölsken A,Stache C,Schlaffer SM,Flitsch J,Fahlbusch R,Buchfelder M,Buslei R

    更新日期:2014-12-01 00:00:00

  • Cushing's disease.

    abstract::Cushing's disease, i.e., pituitary ACTH-secreting adenoma causing excess glucocorticoid secretion, is a rare disease with significant mortality and morbidity. Timely diagnosis and appropriate treatment can alter the course of the disease and are therefore mandatory. First step of the diagnostic work-up is the endogeno...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-006-0407-6

    authors: De Martin M,Pecori Giraldi F,Cavagnini F

    更新日期:2006-01-01 00:00:00

  • Cis-unsaturated free fatty acids block VIP-mediated GH and PRL secretion by perturbing the cAMP/protein kinase A pathway.

    abstract::Cis-unsaturated free fatty acids (FFA) like oleic acid are strong blockers of both basal and stimulated GH secretion in vivo by acting directly on the somatotroph cell. Several lines of evidence suggest that this inhibitory action is the result of a perturbation of the function of several plasma membrane integral prot...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1023/a:1009962624036

    authors: Pérez FR,Camiña JP,Menéndez C,Beiras A,Casabiell X,Casanueva FF

    更新日期:1998-04-01 00:00:00

  • Fatal inflammatory hypophysitis.

    abstract::A young female patient presented as an acute medical emergency with hypoglycaemia. Investigations revealed panhypopituitarism and an inflammatory pituitary mass. An antibody screen was negative for anti-neutrophil cytoplasmic antibodies with cytoplasmic distribution (cANCA). Pituitary histology showed lymphocytic infi...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-007-0016-z

    authors: McIntyre EA,Perros P

    更新日期:2007-01-01 00:00:00

  • A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred.

    abstract::Familial neurohypophyseal diabetes insipidus (FNDI) is mostly an autosomal dominant inherited disorder presenting with severe polydipsia and polyuria typically in early childhood. To date, 69 different variations in the AVP gene encoding the AVP prohormone have been identified in autosomal dominant FNDI (adFNDI). In t...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-012-0392-x

    authors: Birkegaard C,Christensen JH,Falorni A,Marzotti S,Minarelli V,Gregersen N,Rittig S

    更新日期:2013-06-01 00:00:00

  • Suprasellar granular cell tumor of the neurohypophysis: surgical outcome of a very rare tumor.

    abstract:PURPOSE:Granular cell tumors of the neurohypophysis are rare, solitary lesions, mostly presenting in the adult age. They rarely grow to a sufficient size to cause mass effect related symptoms and they may be found in most cases incidentally at autopsy. Because of their rarity as of now they have been described only as ...

    journal_title:Pituitary

    pub_type: 杂志文章

    doi:10.1007/s11102-016-0704-7

    authors: Gagliardi F,Spina A,Barzaghi LR,Bailo M,Losa M,Terreni MR,Mortini P

    更新日期:2016-06-01 00:00:00

  • Screening for Cushing's syndrome: is it worthwhile?

    abstract:INTRODUCTION:Cushing's syndrome (CS) is a rare disease characterized by a collection of signs and symptoms, also common in the general population without elevated cortisol secretion. During the last years more patients with CS are identified earlier and with milder disease. Many of these patients are diagnosed during s...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1007/s11102-015-0634-9

    authors: Shimon I

    更新日期:2015-04-01 00:00:00

  • Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly.

    abstract::Most patients with acromegaly have some degree of insulin resistance. The principal mediator of insulin resistance in acromegaly is hypersecretion of growth hormone. Growth hormone acts at several levels to block insulin actions including inhibiting phosphorylation of the insulin receptor and one of its principal sign...

    journal_title:Pituitary

    pub_type: 杂志文章,评审

    doi:10.1023/a:1023321421760

    authors: Clemmons DR

    更新日期:2002-01-01 00:00:00